Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape

Giovanni Vincenzo Gaudio, Giuseppe Derosa, Giuseppe De Angelis, John Tremamondo, Alessandro Lupi

Open source

DOI
10.1007/s40256-026-00830-8
Published
2026-10-21
Container
American Journal of Cardiovascular Drugs
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40256-026-00830-8,
  title = {Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape},
  author = {Giovanni Vincenzo Gaudio and Giuseppe Derosa and Giuseppe De Angelis and John Tremamondo and Alessandro Lupi},
  year = {2026},
  journal = {American Journal of Cardiovascular Drugs},
  doi = {10.1007/s40256-026-00830-8},
  url = {https://doi.org/10.1007/s40256-026-00830-8}
}

RIS

TY  - JOUR
TI  - Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape
AU  - Giovanni Vincenzo Gaudio
AU  - Giuseppe Derosa
AU  - Giuseppe De Angelis
AU  - John Tremamondo
AU  - Alessandro Lupi
PY  - 2026
JO  - American Journal of Cardiovascular Drugs
DO  - 10.1007/s40256-026-00830-8
UR  - https://doi.org/10.1007/s40256-026-00830-8
ER  - 

APA

Gaudio, G. V., Derosa, G., Angelis, G. D., Tremamondo, J., & Lupi, A. (2026). Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00830-8

Source records